Novel 4,4′-diether-2,2′-bipyridine cisplatin analogues are more effective than cisplatin at inducing apoptosis in cancer cell lines

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 3, 2010, Pages 1163-1170

  Vo, Van ^b   Kabuloglu Karayusuf, Zeynep G ^b   Carper, Stephen W ^b   Bennett, Byron L ^a   Evilia, Caryn ^a  

^a IDAHO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NEVADA   (United States)

Author keywords

2,2 Bipyridine; A549; Cisplatin; DU 145; MDA MB 435

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 4,4' DIETHER 2,2' BIPYRIDINE; BIPYRIDINE; CARBOPLATIN; CISPLATIN; CISPLATIN DERIVATIVE; DICHLORO[4,4' BIS(3 METHOXYPROPYL) 2,2' BIPYRIDINE]PLATINUM; DICHLORO[4,4' BIS(METHOXY)2,2' BIPYRIDINE]PLATINUM; OXALIPLATIN; SATRAPLATIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IONIZING RADIATION; LUNG CANCER; MELANOMA; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION;

2,2'-DIPYRIDYL; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; NEOPLASMS; PROSTATIC NEOPLASMS;

EID: 75149190465     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.12.047     Document Type: Article

References (32)

1. In: DeVita V.T.J., Hellman S., and Rosenberg S.A. (Eds). Cancer of the Testis (2001), Lippincott Williams & Wilkins Philadelphia
2. Wang D., and Lippard S.J. Nat. Rev. 4 (2005) 307
3. Todd R.C., and Lippard S.J. Metallomics 1 (2009) 280
4. Arnesano F., and Natile G. Coord. Chem. Rev. 253 (2009) 2070
5. Shah N., and Dizon D.S. Future Oncol. 5 (2009) 33
6. Lassi K., and Dawson N.A. Curr. Opin. Oncol. 21 (2009) 260
7. Sadler P.J. Chem. Ind. 23 (2009) 18
8. See:. Mackay F.S., et al. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 20743
9. Chen Y., Guo Z., Parsons S., and Sadler P.J. Chem. Eur. J. 4 (1998) 672
10. Chen Y., Guo Z., Parkinson J.A., and Sadler P.J. J. Chem. Soc., Dalton Trans. (1998) 3577
11. Pauwels B., Korst A.E.C., Lambrechts H.A.J., Pattyn G.G.O., Pooter C.M.J., Lardon F., and Vermorken J.B. Cancer Chemother. Pharmacol. 58 (2006) 219
12. Kabuoglu-Karayusuf, Z.G. Cisplatin analogues containing 4,4′-Bis[Alkyl]-2-2′-biopyridine derivatives, Thesis (M.S.), University of Nevada, Las Vegas, 2007.
13. Bennett B.L., Robins K.A., Tennant R., Elwell K., Ferri F., Bashta I., and Aguinaldo G. J. Fluorine Chem. 127 (2006) 140
14. Hope E.G., Levason W., and Powell N.A. Inorg. Chim. Acta 115 (1986) 187
15. Boeckman H.J., Trego K.S., and Turchi J.J. Mol. Cancer Res. 3 (2005) 277
16. Ormerod M.G., ÓNeill C.F., Robertson D., and Harrap K.R. Exp. Cell Res. 211 (1994) 231
17. Henkels K.M., and Turchi J.J. Cancer Res. 57 (1997) 4488
18. Calsou P., and Salles B. Cancer Chemother. Pharmacol. 32 (1993) 85
19. Koberle B., Grimaldi K.A., Sunters A., Hartley J.A., Kelland L.R., and Masters J.R. Int. J. Cancer 70 (1997) 551
20. Reed S.H. DNA Repair 4 (2005) 909
21. Van, V. 'Cytotoxicity of novel cisplatin analogs in lung, prostate and breast cancer cells', Thesis (M.S.), University of Nevada, Las Vegas, 2007.
22. Elwell K.E., Hall C., Thaker S., Giraud Y., Bennett B.L., Bae C., and Carper S.W. Bioorg. Med. Chem. 14 (2006) 8692
23. Lu H.-F., Sun X., Xu L., Lou L.-G., and Lin G.-Q. Eur. J. Med. Chem. 44 (2009) 482
24. Bégué J.-P., and Bonnet-Delpon D. Bioorganic and Medicinal Chemistry of Fluorine (2008), John wiley and Sons, Hoboken NJ
25. Timperley C.M., and White W.E. J. Fluorine Chem. 123 (2003) 65
26. Wang D., and Lippard S.J. Nat. Rev. Drug Disc. 4 (2005) 307
27. Stewart D.J., Molepo J.M., Eapen L., Montpetit V.A., Goel R., Wong P.T., Popovic P., Taylor K.D., and Raaphorst G.P. Int. J. Radiat. Oncol. Biol. Phys. 28 (1994) 631
28. Lawrence T.S., Blackstock A.W., and McGinn C. Semin. Radiat. Oncol. 13 (2003) 13
29. Fehlauer F., Muench M., Rades D., Stalpers L.J.A., Leenstra S., van der Valk P., Slotman B., Smid E.J., and Sminia P. J. Cancer Res. Clin. Oncol. 131 (2005) 723
30. Wilson G.D., Bentzen S.M., and Harari P.M. Semin. Radiat. Oncol. 16 (2006) 2
31. Rave-Fraenk M., Schmidberger H., Christiansen H., Boll C., Lehmann J., and Weiss E. Int. J. Radiat. Biol. 83 (2007) 41
32. Torigoe T., Izumi H., Ishiguchi H., Yoshida Y., Tanabe M., Yoshida T., Igarashi T., Niina I., Wakasugi T., Imaizumi T., Momii Y., Kuwano M., and Kohno K. Curr. Med. Chem.-Anti-Cancer Agents 5 15 (2005)